Professor, Department of Population Health
Magdalena Cerdá is a Professor and Director of the Center for Opioid Epidemiology and Policy, at the Department of Population Health at NYU Grossman School of Medicine. She obtained her doctorate from the Harvard University School of Public Health in 2006, and is a former Robert Wood Johnson Health and Society Scholar. Her research focuses on the effects that state and national drug and health policies have on substance abuse trends, and on the ways the urban context shapes violence. Current funded research focuses on the impact that cannabis laws and opioid policies have on substance abuse, mental illness, and associated health problems in the United States and South America. In addition, she is evaluating the impact that firearm disqualifications based on mental illness and substance abuse criteria could have on population-level rates of firearm-related mortality.
The Center for Opioid Epidemiology and Policy at NYU Langone was launched in 2018 to serve as a central source of research on the United States’ rapidly shifting opioid overdose epidemic. Comprised of a multidisciplinary team of faculty and staff, the center focuses on tracking and predicting trends in opioid morbidity and mortality, informing evidence-based policies and programs to prevent opioid misuse, disorder, and overdose in populations nationally and globally, and training the next generation of researchers in this area. The Center's work also extends into other areas of substance use research related to stimulants and marijuana, and includes examining the intersection of the COVID-19 pandemic and the overdose epidemic.
646-501-3649
180 Madison Avenue 4-16
New York, NY 10016
Director, Center for Opioid Epidemiology and Policy
Director, Division of Epidemiology, Department of Population Health
DrPH from Harvard Medical School
University of Michigan, Robert Wood Johnson Foundation Health and Society Scholars Program
Preventive medicine. 2025 Mar 29; 194:108276
American journal of epidemiology. 2025 Mar 04; 194(3):869-870
International journal on drug policy. 2025 Mar; 137:104713
International journal on drug policy. 2025 Feb; 136:104687